# Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric Cancers

> **NCT00154726** · PHASE2 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 40 (—)

## Conditions studied

- Locally Advanced and Recurrent/Metastatic Gastric Cancer

## Interventions

- **DRUG:** Paclitaxel-HDFL

## Key facts

- **NCT ID:** NCT00154726
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-04
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** 40 (—)
- **Last updated:** 2005-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00154726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00154726, "Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric Cancers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00154726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*